About this Research Topic
According to WHO, non-communicable diseases (NCDs) kill 41 million people each year, of which 17 million people die before age 70. Cardiovascular disease accounts for most NCD deaths, followed by cancer, chronic respiratory disease, and diabetes. This does not include deaths from neurodegenerative and psychiatric diseases which are also on the rise globally. Of all NCD deaths, 77% occur in low- to middle-income countries, where access to medicines to treat NCDs is often limited by low availability or affordability. Even rich countries are struggling under the burden of using a medical model to treat NCDs.
The medical model generally assumes that these conditions are chronic, progressive, and irreversible; and that they require pharmaceutical medication. An increasing number of clinicians, researchers, and patients are exploring an alternative approach that utilizes ketogenic metabolic therapy (KMT) that has been shown to reverse the symptoms and progression of many NCDs including type 2 diabetes, chronic kidney disease, and bipolar disease, amongst others.
KMT is among the most rigorously studied eating patterns and has long been established as a safe and evidence-based treatment for intractable epilepsy. There are currently over 300 registered clinical trials using KMT as an intervention for a wide range of NCDs. Its promising effects might be attributed to its mechanisms of action that increase mitochondrial function, decrease oxidative stress, and reduce inflammation.
The 1st International Keto Live® Sports Conference & the 4th International Keto Live® Conference organized by the European Keto Live® Centre (EKLC) and the Swiss Association for Ketogenic Metabolic Therapies (SAKMT), will take place in June 2024 in St. Moritz, Switzerland and will be dedicated to practical application of KMTs, covering a wide range of topics including sports and exercise nutrition; nutrition in neurology and psychiatry; nutrition in insulin resistance, cardiovascular disease (CVD), cancer, diabetes and chronic kidney disease (CKD) among others.
Our research topic will explore the relationships between metabolic health, insulin resistance, and the onset of NCDs and the role of ketone and glucose metabolism in the development and treatment of NCDs. We welcome high-quality original research, reviews, case reports, opinion & perspective articles focused on the physiological underpinnings and application of KMT in a wide range of fields of medicine.
The medical model generally assumes that these conditions are chronic, progressive, and irreversible; and that they require pharmaceutical medication. An increasing number of clinicians, researchers, and patients are exploring an alternative approach that utilizes ketogenic metabolic therapy (KMT) that has been shown to reverse the symptoms and progression of many NCDs including type 2 diabetes, chronic kidney disease, and bipolar disease, amongst others.
KMT is among the most rigorously studied eating patterns and has long been established as a safe and evidence-based treatment for intractable epilepsy. There are currently over 300 registered clinical trials using KMT as an intervention for a wide range of NCDs. Its promising effects might be attributed to its mechanisms of action that increase mitochondrial function, decrease oxidative stress, and reduce inflammation.
The 1st International Keto Live® Sports Conference & the 4th International Keto Live® Conference organized by the European Keto Live® Centre (EKLC) and the Swiss Association for Ketogenic Metabolic Therapies (SAKMT), will take place in June 2024 in St. Moritz, Switzerland and will be dedicated to practical application of KMTs, covering a wide range of topics including sports and exercise nutrition; nutrition in neurology and psychiatry; nutrition in insulin resistance, cardiovascular disease (CVD), cancer, diabetes and chronic kidney disease (CKD) among others.
Our research topic will explore the relationships between metabolic health, insulin resistance, and the onset of NCDs and the role of ketone and glucose metabolism in the development and treatment of NCDs. We welcome high-quality original research, reviews, case reports, opinion & perspective articles focused on the physiological underpinnings and application of KMT in a wide range of fields of medicine.
Keywords: ketogenic, metabolic therapy, metabolic syndrome, insulin resistance, obesity, diabetes, T2D, mental health, T1D, neurodegenerative, bipolar disorder, schizophrenia, psychiatric disease, cancer, CVD, NCDs
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
